XT Hi-Tech

• 06/12/2022
• Series A
• $35,000,000

As the venture arm of XT Holdings, we back unique technology companies that emerge from Israel and have been doing so since 1997.

Our track record empowers us to invest in those companies we believe will be the next category leaders – even in categories that are still under construction…

We believe in true partnerships, so before joining we try to learn how we can work together all the way, through the highs and lows that are always part of the journey.

When partnering, we see it as our mission to make management teams as successful as possible, supporting them with capital, a broad network of connections, operational know-how, and 24/7 advice - all based on decades of experience in taking companies from any stage to category leadership.

Our venture team has a strong mix of entrepreneurial, operational, and investment expertise and we are active members of our companies’ board of directors.

By implementing our strategy, we managed to be a significant ingredient in the creation of market leaders such as Phytech, Checkmarx, Enzymotec, Cymbio, Sofwave, and Lumenis. In fact, since inception, we have invested in over 80 companies, which resulted in over 30 IPOs and M&As, 15 portfolio companies, and 3 unicorns.

We invite you to reach out to us via hitech@xtholdings.com.

---

---